Solar Orbiter observations show that a medium-class solar flare formed through cascading magnetic reconnection events, ...

LOS ANGELES, June 25 (Reuters) - Nearly two-thirds of patients who started on weight-loss drugs Wegovy or Zepbound last year were still taking them a year later, according to an analysis of U.S.

The increase comes after private payrolls declined by a revised 29,000 in November.

Gov. Gretchen Whitmer's social media feeds are flooded with hundreds of commenters objecting to AI data centers.

Is America seeing a religious revival, or is the anecdotal evidence of another Great Awakening simply evidence of anecdotes? I set out to attempt to answer that question with Ryan Burge, a nationally ...

There are over a thousand planned or existing data centers across the US, according to a BI investigation. Major tech companies are racing to construct even more as the AI boom continues. But at what ...

By Maxwell Radwin Deforestation in Colombia appears to have declined in 2025, with notable reductions in several departments ...

Tirzepatide produced significant weight loss, reduced insulin requirements, and improved glucose control without increasing hypoglycemia when used off-label in adults with type 1 diabetes (T1D), new ...

Please provide your email address to receive an email when new articles are posted on . Upadacitinib is an oral JAK inhibitor under investigation for the treatment of multiple dermatologic indications ...

I’m sorry, you've heard this 100 times, but you’ve got to get your data right,” The Vitamin Shoppe’s Andrew Laudato said at ...